Related Experiment Video
Updated: Jun 5, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Ethical, legal, and social implications (ELSI) of microdose clinical trials
1Molecular Imaging Center, National Institute of Radiological Sciences, Anagawa 4-9-1, Inage, Chiba 263-8555 Japan. chieko.kurihara@nifty.ne.jp
Abstract:
A "microdose clinical trial" (microdosing) is one kind of early phase exploratory clinical trial, administering the compound at doses estimated to have no pharmacological or toxicological effects, aimed at screening candidates for further clinical development. This article's objective is to clarify the ethical, legal, and social implications (ELSI) of such an exploratory minimum-risk human trial. The definition and non-clinical study requirements for microdosing have been harmonized among the European Union (EU), United States (US), and Japan. Being conducted according to these regulations, microdosing seems to be ethically well justified in terms of respect for persons, beneficence, justice, human dignity, and animal welfare. Three big projects have been demonstrating the predictability of therapeutic dose pharmacokinetics from microdosing. The article offers suggestions as how microdosing can become a more useful and socially accepted strategy.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Regulation
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinical Trials: Overview
Dosage Regimen: Individualization
Ethics in Research
